Tuesday, June 2, 2026
NewsezeNews with Rewards · Earn while you read
+5 credits / query
Top StoriesLocalWorldPoliticsTech & AIBusiness & MarketsHealthSportsVoicesEditorialForeign StationsBuildeze
Rewards · Earn $$$ Newsroom Verified Sources Networks Earn Anywhere Sellpages Students · Free Pro Member Benefits Archives Watchlist Investigations Local Watch Contact
Back to medicine
medicine

Only 20% of Sunscreens Meet Safety Standards. What to Know Before You Buy

Newseze Wire·Sun, May 31, 7:31 PMWire: Healthline
Open original source Read full story (in-site)
Only 20% of Sunscreens Meet Safety Standards. What to Know Before You Buy

The EWG reports that only 20% of sunscreens meet safety standards. Image Credit: Ani Dimi/Stocksy Only about 20% of sunscreens meet leading safety and efficacy standards, according to a recent report from the Environmental Working Group…

Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap "Open original source" above to read their full reporting and support the contributing newsroom directly.

Newseze Analysis99 words · original commentary · full read loading…
The EWG reports that only 20% of sunscreens meet safety standards. Image Credit: Ani Dimi/Stocksy Only about 20% of sunscreens meet leading safety and efficacy standards, according to a recent report from the Environmental Working Group… The story falls into Newseze's medicine desk and is being actively tracked by our editorial team. Calm framing, primary-source references, and respectful tone — every Newseze story is scored for drama and conspiracy before it reaches you. Worth knowing: Newseze refreshes its newsroom every 15 minutes and flags fast-moving local and breaking news as it develops. Watch this page for updates. Reporting: Healthline.
Reader CommentsBe the first reader · Subscribe to join

No comments yet. Be the first.

Related stories

Lilly's Retatrutide Achieves Biggest Weight Loss in Trial History, Outpacing Current GLP-1 Drugs and Surgery
MEDICINEcentertrust 89
Lilly's Retatrutide Achieves Biggest Weight Loss in Trial History, Outpacing Current GLP-1 Drugs and Surgery

Why it mattersA new triple-hormone drug shows clinical results that could reshape obesity treatment and reduce demand for invasive bariatric surgery, potentially lowering costs and expanding access to effective weight management.

A new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1 drugs and bariatric surgery. Image Credit: Scott Olson/Getty …

ChellaBy Chella·2d ago
WireHealthline
Full Analysis Comment PostRead →